Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jan 31, 2017 | $18.0B |
| FY2018, ended Jan 31, 2018 | $25.2B |
| FY2019, ended Jan 31, 2019 | $32.3B |
| FY2020, ended Jan 31, 2020 | $43.2B |
| FY2021, ended Jan 31, 2021 | $60.9B |
| FY2022, ended Jan 31, 2022 | $54.3B |
| FY2023, ended Jan 31, 2023 | $46.2B |
| FY2024, ended Jan 31, 2024 | $54.7B |
| FY2025, ended Jan 31, 2025 | $66.3B |
| FY2026, ended Jan 31, 2026 | $53.4B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $48.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jan 31, 2017 | $2.03B |
| FY2018, ended Jan 31, 2018 | $2.06B |
| FY2019, ended Jan 31, 2019 | $2.57B |
| FY2020, ended Jan 31, 2020 | $3.27B |
| FY2021, ended Jan 31, 2021 | $3.79B |
| FY2022, ended Jan 31, 2022 | $4.39B |
| FY2023, ended Jan 31, 2023 | $5.00B |
| FY2024, ended Jan 31, 2024 | $5.50B |
| FY2025, ended Jan 31, 2025 | $6.13B |
| FY2026, ended Jan 31, 2026 | $7.21B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $7.79B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jan 31, 2017 | −$582M | $93.7M |
| FY2018, ended Jan 31, 2018 | −$567M | −$49.8M |
| FY2019, ended Jan 31, 2019 | −$80.8M | $310M |
| FY2020, ended Jan 31, 2020 | $215M | $1.36B |
| FY2021, ended Jan 31, 2021 | $1.21B | $1.35B |
| FY2022, ended Jan 31, 2022 | $497M | $1.48B |
| FY2023, ended Jan 31, 2023 | $823M | $2.03B |
| FY2024, ended Jan 31, 2024 | $906M | $1.28B |
| FY2025, ended Jan 31, 2025 | $1.11B | $1.57B |
| FY2026, ended Jan 31, 2026 | $1.12B | $2.41B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $1.64B | $2.84B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jan 31, 2017 | $1.21B |
| FY2018, ended Jan 31, 2018 | $1.08B |
| FY2019, ended Jan 31, 2019 | $886M |
| FY2020, ended Jan 31, 2020 | $1.77B |
| FY2021, ended Jan 31, 2021 | $1.77B |
| FY2022, ended Jan 31, 2022 | $1.53B |
| FY2023, ended Jan 31, 2023 | $1.95B |
| FY2024, ended Jan 31, 2024 | $1.89B |
| FY2025, ended Jan 31, 2025 | $1.60B |
| FY2026, ended Jan 31, 2026 | $2.25B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $4.10B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jan 31, 2017 | $1.49B |
| FY2018, ended Jan 31, 2018 | $1.59B |
| FY2019, ended Jan 31, 2019 | $2.09B |
| FY2020, ended Jan 31, 2020 | $2.55B |
| FY2021, ended Jan 31, 2021 | $1.65B |
| FY2022, ended Jan 31, 2022 | $3.00B |
| FY2023, ended Jan 31, 2023 | $2.30B |
| FY2024, ended Jan 31, 2024 | $2.30B |
| FY2025, ended Jan 31, 2025 | $2.60B |
| FY2026, ended Jan 31, 2026 | $2.50B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $3.49B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.4% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jan 31, 2017 | 221M |
| FY2018, ended Jan 31, 2018 | 218M |
| FY2019, ended Jan 31, 2019 | 220M |
| FY2020, ended Jan 31, 2020 | 220M |
| FY2021, ended Jan 31, 2021 | 220M |
| FY2022, ended Jan 31, 2022 | 217M |
| FY2023, ended Jan 31, 2023 | 215M |
| FY2024, ended Jan 31, 2024 | 215M |
| FY2025, ended Jan 31, 2025 | 213M |
| FY2026, ended Jan 31, 2026 | 211M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 209M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2017, ended Jan 31, 2017 | $622M | $222M | $120M | — |
| FY2018, ended Jan 31, 2018 | $699M | $261M | $94.4M | — |
| FY2019, ended Jan 31, 2019 | $294M | $250M | $90.9M | $44.8M |
| FY2020, ended Jan 31, 2020 | $443M | $362M | $93.7M | — |
| FY2021, ended Jan 31, 2021 | $552M | $398M | $114M | $38.0M |
| FY2022, ended Jan 31, 2022 | $1.08B | $555M | $114M | $6.00M |
| FY2023, ended Jan 31, 2023 | $1.10B | $657M | $124M | $10.0M |
| FY2024, ended Jan 31, 2024 | $795M | $703M | $130M | — |
| FY2025, ended Jan 31, 2025 | $852M | $683M | $121M | — |
| FY2026, ended Jan 31, 2026 | $1.40B | $788M | $137M | — |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $1.59B | $706M | $138M | — |
Valuation
At current price- Market Cap
- $50.6B
- P/E
- 30.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.5×
- Price / Book
- 15.0×
- EV / EBITDA
- 22.3×
Growth
Trailing 12 months- Revenue (TTM)
- $7.79B
- Revenue Growth YoY
- 17.9%
- Revenue CAGR 3Y
- 12.9%
- Revenue CAGR 5Y
- 13.7%
- EPS Growth YoY
- 60.5%
- Net Income Growth YoY
- 57.4%
Profitability
Trailing 12 months- Gross Margin
- 91.2%
- Operating Margin
- 26.2%
- Net Margin
- 21.1%
- FCF Margin
- 36.4%
- Return on Equity
- 53.9%
Earnings
Trailing 12 months- Net Income
- $1.64B
- EPS (diluted)
- $7.72
- EBITDA
- $2.24B
- Operating Income
- $2.04B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $4.10B
- Total Debt
- $3.49B
- Net Cash
- $604M
- Total Assets
- $13.0B
- Total Liabilities
- $9.60B
- Shareholders' Equity
- $3.38B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.90B
- Capital Expenditure
- $57.0M
- Free Cash Flow
- $2.84B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.32
Every ratio is calculated from the company’s reported figures.